Icon

TEKAMLO (nda022545)- (EQ 150MG BASE;EQ 5MG BASE,EQ 150MG BASE;EQ 10MG BASE,EQ 300MG BASE;EQ 5MG BASE,EQ 300MG BASE;EQ 10MG BASE)

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE NOVARTIS
EQ 150MG BASE;EQ 5MG BASE,EQ 150MG BASE;EQ 10MG BASE,EQ 300MG BASE;EQ 5MG BASE,EQ 300MG BASE;EQ 10MG BASE
No Yes
2029-Dec-21 2012-Mar-05
None None
None No
Tekamlo is a combination of aliskiren, a renin inhibitor, and amlodipine, a dihydropyridine calcium channel blocker, indicated for the treatment of hypertension, to lower blood pressure:  As initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals.  In patients not adequately controlled with monotherapy.  As a substitute for its titrated components.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 150MG BASE;EQ 5MG BASE ** ** - - -
EQ 150MG BASE;EQ 10MG BASE ** ** - - -
EQ 300MG BASE;EQ 5MG BASE ** ** - - -
EQ 300MG BASE;EQ 10MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.